Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00206011
Other study ID # 06-CMF-01
Secondary ID
Status Completed
Phase Phase 4
First received
Last updated
Start date April 2003
Est. completion date January 2009

Study information

Verified date August 2020
Source AO Innovation Translation Center
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study is a comparison of open surgery versus an endoscopic approach in condylar neck fractures; it will look at functional outcome, cosmetic outcome and patient satisfaction.


Description:

The primary outcome measure is functional outcome based on the Helkimo dysfunction index.


Recruitment information / eligibility

Status Completed
Enrollment 134
Est. completion date January 2009
Est. primary completion date October 2008
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Adult patient > 18 years

- Unilateral or bilateral fracture of the condylar neck

- Inclination of the condyle > 30%

- Severe dislocation

- Severe pain upon palpation/movement

- Eligible for open reduction and internal fixation of the fracture

- Amenable to endoscopic as well as open surgery

Exclusion Criteria:

- High or intracapsular condylar neck fracture

- Very low fractures that can be reduced intraorally

- CMF malfunctioning

- Drug or alcohol abuse

- General or local conditions that adversely affect bone physiology

- Physical or mental incapacity to sign informed consent

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Endoscopic surgery
Open surgical intervention compared to endoscopic intervention

Locations

Country Name City State
Germany Universitaestklinik Freiburg, Klinik für Mund- Gesichts- und Kieferchirurgie Freiburg

Sponsors (1)

Lead Sponsor Collaborator
AO Clinical Investigation and Publishing Documentation

Country where clinical trial is conducted

Germany, 

Outcome

Type Measure Description Time frame Safety issue
Primary Functional outcome based on the Helkimo dysfunction index 3 months
Secondary Complication rate 24 months
Secondary Cost effectiveness 24 months